Liu Shuzhen相关文献与解析，生知库 | 链接生命科学的每一步

Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report

弥漫性大B细胞淋巴瘤与PD-1抑制剂治疗在胃腺癌患者中的时间关联性：病例报告

doi:10.3389/fimmu.2026.1763711

Jiang, Yiqing; Wu, Kun; Hu, Jia; Yu, Mingxin; Xu, Yuhang; Xu, Zihan; Cao, Rongxuan; Zhang, Yi; Gao, Yanfang; Liu, Shuzhen; Ding, Yanhong

Ferroptosis in diabetes-associated cognitive dysfunction: mechanisms and therapeutic potential

糖尿病相关认知功能障碍中的铁死亡：机制和治疗潜力

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2026.1756129

Liu, Hang; Qian, Siqi; Liu, Shuzhen; Xiao, Wenbiao; You, Yijie; Zeng, Yi

Comparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults

比较新型胰岛素抵抗、脂质代谢和肥胖指标对成人发生血脂异常风险的预测能力

期刊:BMC Endocrine Disorders

影响因子:3.3

doi:10.1186/s12902-026-02185-2

Liang, Yujian; Cai, Jiansheng; Mo, Xiaoting; Liu, Qiumei; Rong, Jiahui; Zhao, Linhai; Luo, Lei; Zhang, Tiantian; Wu, Songju; Jin, Wenjia; Guan, Qinyi; Teng, Kaisheng; Zhong, Liuyong; Li, Xiaolin; Chen, Pengfeng; Qiu, Tian; Liu, Shuzhen; Qin, Jian; Zhang, Zhiyong

Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway

精氨酸代谢途径抑制肿瘤的分子机制和疗法

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2026.1774392

Xu, Yuhang; Yu, Mingxin; Zhang, Yi; Jiang, Yiqing; Zhu, Haiyan; He, Shujuan; Yu, Guohua; Li, Niannian; Liu, Shuzhen; Liu, Bin

Fecal microbiota transplantation improves functional constipation through the gut microbiome-bile acid-receptor axis

粪便微生物移植通过肠道微生物群-胆汁酸受体轴改善功能性便秘。

期刊:Frontiers in Medicine

影响因子:3

doi:10.3389/fmed.2026.1751593

Wen, Dongxu; Liu, Shuzhen; Wu, Yukun; Zhang, Haixuan; Zhang, Kun

Intracellular Ca(2+) is not essential for SHH signaling but is promoted by Shh ligand in embryonic fibroblasts.

细胞内 Ca(2+) 对于 SHH 信号传导并非必需，但 Shh 配体可促进胚胎成纤维细胞中的 Ca(2+) 信号传导。

期刊:BMC Molecular and Cell Biology

影响因子:2.7

doi:10.1186/s12860-026-00567-x

Shi Xuanming, Wang Zhaomin, Li Shupeng, Pan Yiming, Shen Bing, Liu Shuzhen

Engineered Genetic Circuits Activated by Bezafibrate Improve ESC-Based TAA Cancer Vaccine Efficacy and PD-L1 Nanobody Therapy.

苯扎贝特激活的工程化基因回路可提高基于 ESC 的 TAA 癌症疫苗的疗效和 PD-L1 纳米抗体疗法

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202500272

Jin Meiling, Liu Shuzhen, Zhan Mingshuo, Huang Jian-Dong

Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axis.

将 MDM2 抑制剂 RG7388 用于 TP53 突变型 NSCLC：通过 ROS/p-p38/NOXA/caspase-3/GSDME 轴的 p53 非依赖性细胞焦亡机制

期刊:Cell Death & Disease

影响因子:9.6

doi:10.1038/s41419-025-07770-2

Tang Gaoyan, Cao Xuelei, Chen Jiaqi, Hui Fu, Xu Na, Jiang Yiqing, Lu Hongmin, Xiao Haifeng, Liang Xiuming, Ma Mingzhe, Qian Yu, Liu Dongli, Wang Zhenlu, Liu Shuzhen, Yu Guohua, Sun Lei

Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations

EGFR突变型非小细胞肺癌合并TP53或KRAS共突变后，TKI耐药患者接受化疗-免疫治疗的疗效及预后分析

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1684089

Nie, Yuhui; Song, Chen; Wu, Kun; Yu, Mingxin; Hu, Jia; Liu, Shuzhen; Hui, Fu

Mitofusin-2 suppresses tumor immune escape through EGFR/STAT3-mediated PD-L1 transcription.

Mitofusin-2 通过 EGFR/STAT3 介导的 PD-L1 转录抑制肿瘤免疫逃逸。

Temporal association of diffuse large B-cell lymphoma with PD-1 inhibitor therapy in a patient with gastric adenocarcinoma: a case report

弥漫性大B细胞淋巴瘤与PD-1抑制剂治疗在胃腺癌患者中的时间关联性：病例报告

Ferroptosis in diabetes-associated cognitive dysfunction: mechanisms and therapeutic potential

糖尿病相关认知功能障碍中的铁死亡：机制和治疗潜力

Comparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults

比较新型胰岛素抵抗、脂质代谢和肥胖指标对成人发生血脂异常风险的预测能力

Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway

精氨酸代谢途径抑制肿瘤的分子机制和疗法

Fecal microbiota transplantation improves functional constipation through the gut microbiome-bile acid-receptor axis

粪便微生物移植通过肠道微生物群-胆汁酸受体轴改善功能性便秘。

Intracellular Ca(2+) is not essential for SHH signaling but is promoted by Shh ligand in embryonic fibroblasts.

细胞内 Ca(2+) 对于 SHH 信号传导并非必需，但 Shh 配体可促进胚胎成纤维细胞中的 Ca(2+) 信号传导。

Engineered Genetic Circuits Activated by Bezafibrate Improve ESC-Based TAA Cancer Vaccine Efficacy and PD-L1 Nanobody Therapy.

苯扎贝特激活的工程化基因回路可提高基于 ESC 的 TAA 癌症疫苗的疗效和 PD-L1 纳米抗体疗法

Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axis.

将 MDM2 抑制剂 RG7388 用于 TP53 突变型 NSCLC：通过 ROS/p-p38/NOXA/caspase-3/GSDME 轴的 p53 非依赖性细胞焦亡机制

Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations

EGFR突变型非小细胞肺癌合并TP53或KRAS共突变后，TKI耐药患者接受化疗-免疫治疗的疗效及预后分析